Gujarat Cancer & Research Institute

Ahmedabad 380016

1 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Ovarian Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer — Stopped early